Transthyretin
Overview
Transthyretin is a protein that is primarily produced in the liver and is responsible for transporting thyroxine and retinol. It is also known as prealbumin and is involved in various physiological processes, including the maintenance of the blood-brain barrier and the prevention of amyloid fibril formation.
AL Amyloidosis Therapeutics Market
The AL amyloidosis therapeutics market is expected to experience significant growth from 2023 to 2031, according to a comprehensive analysis and growth forecast. The market will be driven by advancements in technology, manufacturers, regions, type, and application. A SWOT analysis of the market has also been conducted to guide the forecast.
Conclusion
Transthyretin plays a crucial role in the human body, and its dysfunction can lead to various diseases, including amyloidosis. The AL amyloidosis therapeutics market is expected to grow in the coming years, and advancements in technology and manufacturing will be key drivers of this growth.